Shi, Zhenzhen
Mhlanga, Adquate
Ishida, Yuji
Josephson, Ari
Collier, Nicholson T.
Abe-Chayama, Hiromi
Tateno-Mukaidani, Chise
Cotler, Scott J.
Ozik, Jonathan
Major, Marian
Feld, Jordan J.
Chayama, Kazuaki
Dahari, Harel
Funding for this research was provided by:
U.S. NIH grants (R01GM121600)
Canadian Institutes of Health Research (#178382)
Japan Agency for Medical Research and Development (JP23fk0310513)
Article History
Received: 23 May 2024
Accepted: 11 December 2024
First Online: 30 December 2024
Declarations
:
: YI and CTM are PhoenixBio employees. KC has received honoraria from Bristol-Myers Squibb and MSD K.K., AbbVie, Gilead Science, Dainippon Sumitomo Pharma and Mitsubishi Tanabe Pharma and research funding from Gilead Science, Dainippon Sumitomo Pharma, MSD K.K., AbbVie, Eisai, TORAY, Otsuka Pharma, Chugai Pharma, Takeda Pharma and Roche. JJF reports research funding and consulting fees from AbbVie and Gilead. All other authors have nothing to disclose.